- Exchange: OTC US
- Sector: Consumer, Non-cyclical
- Industry: Healthcare-Products
- Sub-Industry: Medical Instruments
Snapshot for Elekta AB (EKTAF)
| Open: | - | Day's Range: | - | Volume: | 1,000 |
|---|---|---|---|---|---|
| Previous Close: | 15.3000 | 52wk Range: | 11.5000 - 16.0400 | 1-Yr Rtn: | - |
Key Statistics for EKTAF
| Current P/E Ratio (ttm) | - |
|---|---|
| Estimated P/E(04/2013) | 27.7698 |
| Relative P/E vs. SPX | - |
| Earnings Per Share (SEK) (ttm) | - |
| Est. EPS (SEK) (04/2013) | 3.6420 |
| Est. PEG Ratio | 1.6183 |
| Market Cap (M USD) | 0.00 |
| Shares Outstanding (M) | 0.00 |
| 30 Day Average Volume | 629 |
| Price/Book (mrq) | - |
| Price/Sale (ttm) | - |
| Dividend Indicated Gross Yield | 1.21% |
| Cash Dividend (SEK) | 1.2500 |
| Last Dividend | 09/05/2012 |
| 5 Year Dividend Growth | 37.20% |
| Next Earnings Announcement | 06/05/2013 |
mrq = Most Recent Quarter; ttm = Trailing Twelve Months
Income Statement for EKTAF
Company Profile & Key Executives for EKTAF
Elekta AB produces and sells advanced medical products for treatment of neurological disorders and radiation of cancer. The Company has developed the Gamma Knife, a non-invasive surgical tool for the management of small and hard to locate intracranial lesions, as well as a complete system for stereotactic neurosurgery. Elekta markets worldwide.
| Tomas PuuseppPresident/CEO/Acting VP:EMEA | Hakan BergstromChief Financial Officer |
| Johan SedihnChief Operating Officer | Asa HedinExec VP:Neuroscience |
Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.
Sponsored Financial Commentaries
Advertisement
Top Forex Trading Resources
-
EKTAF News
-
Industry News
Advertisement
- 1
- 2
- 3
- 4
- 5
Advertisement
Sponsored Links
Advertisements
Rate this Page